Skip to main content

Table 1 Comparison of patient characteristics

From: Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis

 

Total

n = 186

Non-survivors

n = 36

Survivors

n = 150

P value

Age (years old)

72 (62–79)

76 (68–81)

71 (61–78)

<0.05

Male

115 (62)

20 (56)

95 (63)

0.39

Infection focus

   

<0.05

 Lung

77 (41)

8 (22)

69 (46)

 

 Abdomen

61 (33)

21 (58)

40 (27)

 

 Skin and soft tissue

13 (7)

3 (8)

10 (7)

 

 Urinary tract

11 (6)

2 (6)

9 (6)

 

 Others

11 (6)

1 (3)

10 (7)

 

 Unknown

13 (7)

1 (3)

12 (8)

 

 Mean blood pressure (mmHg)

78 (67–97)

74 (63–92)

79 (67–97)

0.13

 Heart rate (bpm)

110 (95–120)

111 (95–120)

110 (95–121)

0.77

 Respiratory rate (bpm)

23 (19–28)

24 (20–28)

22 (18–28)

0.28

 Body temperature (°C)

36.9 (36.3-37.9)

36.7 (36.0-37.4)

36.9 (36.4-38.1)

0.06

JAAM DIC score

3 (2–5)

4 (2–6)

3 (2–5)

0.13

JAAM DIC positive rate

87 (47)

21 (58)

66 (44)

0.12

SOFA score

8 (5–11)

11 (8–13)

8 (5–11)

<0.01

 Respiratory

2 (2–3)

2 (1–3)

2 (2–3)

0.87

 Cardiovascular

1 (0–4)

4 (0–4)

1 (0–4)

<0.01

 Liver

0 (0–1)

0 (0–1)

0 (0–1)

0.95

 Renal

1 (0–3)

3 (1–4)

1 (0–3)

<0.01

 Coagulation

1 (0–2)

0 (0–2)

1 (0–2)

0.85

 CNS

1 (0–2)

1 (0–3)

1 (0–2)

0.95

rhs TM

46 (25)

11 (31)

35 (23)

0.37

AT III

28 (15)

6 (17)

22 (15)

0.76

IVIG

92 (49)

21 (58)

71 (47)

0.24

CRRT

44 (24)

17 (47)

27 (18)

<0.01

PMX-DHP

28 (15)

9 (25)

19 (13)

0.06

  1. Data are presented as median (interquartile range) or number (percentage)
  2. JAAM Japanese Association for Acute Medicine, DIC disseminated intravascular coagulation, SOFA sequential organ failure assessment, CNS central nervous system, rhs TM recombinant human soluble thrombomodulin, AT antithrombin, IVIG intravenous immunoglobulin, CRRT continuous renal replacement therapy, PMX-DHP direct hemoperfusion with polymyxin B-immobilized fiber